Skip to main content
. 2023 Aug 14;28(16):6052. doi: 10.3390/molecules28166052

Figure 2.

Figure 2

Percent inhibitory activity of synthesized compounds 46, and 12 as well as baicalein and ivermectin against the SARS-CoV-2 main protease.